Skip to main content
Erschienen in: Clinical and Translational Oncology 5/2017

25.11.2016 | Research Article

Candidate predisposing germline copy number variants in early onset colorectal cancer patients

verfasst von: A. J. Brea-Fernandez, C. Fernandez-Rozadilla, M. Alvarez-Barona, D. Azuara, M. M. Ginesta, J. Clofent, L. de Castro, D. Gonzalez, M. Andreu, X. Bessa, X. Llor, R. Xicola, R. Jover, A. Castells, S. Castellvi-Bel, G. Capella, A. Carracedo, C. Ruiz-Ponte

Erschienen in: Clinical and Translational Oncology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A great proportion of the heritability of colorectal cancer (CRC) still remains unexplained, and rare variants, as well as copy number changes, have been proposed as potential candidates to explain the so-called ‘missing heritability’. We aimed to identify rare high-to-moderately penetrant copy number variants (CNVs) in patients suspected of having hereditary CRC due to an early onset.

Methods/patients

We have selected for genome-wide copy number analysis, 27 MMR-proficient early onset CRC patients (<50 years) without identifiable germline mutations in Mendelian genes related to this phenotype. Rare CNVs were selected by removing all CNVs detected at MAF >1% in the in-house control CNV database (n = 629 healthy controls). Copy number assignment was checked by duplex real-time quantitative PCR or multiplex ligation probe amplification. Somatic mutation analysis in candidate genes included: loss of heterozygosity studies, point mutation screening, and methylation status of the promoter.

Results

We have identified two rare germline deletions involving the AK3 and SLIT2 genes in two patients. The search for a second somatic mutational event in the corresponding CRC tumors showed loss of heterozygosity in AK3, and promoter hypermethylation in SLIT2. Both genes have been previously related to colorectal carcinogenesis.

Conclusions

These findings suggest that AK3 and SLIT2 may be potential candidates involved in genetic susceptibility to CRC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Esteban-Jurado C, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon: International Agency for Research on Cancer; 2013. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Esteban-Jurado C, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon: International Agency for Research on Cancer; 2013.
2.
Zurück zum Zitat Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. New Engl J Med. 2000;343(2):78–85.CrossRefPubMed Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. New Engl J Med. 2000;343(2):78–85.CrossRefPubMed
3.
Zurück zum Zitat Jiao S, Peters U, Berndt S, Brenner H, Butterbach K, Caan BJ, et al. Estimating the heritability of colorectal cancer. Hum Mol Genet. 2014;23(14):3898–905.CrossRefPubMedPubMedCentral Jiao S, Peters U, Berndt S, Brenner H, Butterbach K, Caan BJ, et al. Estimating the heritability of colorectal cancer. Hum Mol Genet. 2014;23(14):3898–905.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3’ exons of TACSTD1. Nat Genet. 2009;41(1):112–7.CrossRefPubMed Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3’ exons of TACSTD1. Nat Genet. 2009;41(1):112–7.CrossRefPubMed
5.
Zurück zum Zitat Jaeger E, Leedham S, Lewis A, Segditsas S, Becker M, Cuadrado PR, et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet. 2012;6:699–703.CrossRef Jaeger E, Leedham S, Lewis A, Segditsas S, Becker M, Cuadrado PR, et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet. 2012;6:699–703.CrossRef
6.
Zurück zum Zitat Fernandez-Rozadilla C, Brea-Fernandez A, Bessa X, Alvarez-Urturi C, Abuli A, Clofent J, et al. BMPR1A mutations in early-onset colorectal cancer with mismatch repair proficiency. Clin Genet. 2013;84(1):94–6.CrossRefPubMed Fernandez-Rozadilla C, Brea-Fernandez A, Bessa X, Alvarez-Urturi C, Abuli A, Clofent J, et al. BMPR1A mutations in early-onset colorectal cancer with mismatch repair proficiency. Clin Genet. 2013;84(1):94–6.CrossRefPubMed
7.
Zurück zum Zitat Venkatachalam R, Ligtenberg MJ, Hoogerbrugge N, Schackert HK, Gorgens H, Hahn MM, et al. Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer. Gastroenterology. 2010;139(6):2221–4.CrossRefPubMed Venkatachalam R, Ligtenberg MJ, Hoogerbrugge N, Schackert HK, Gorgens H, Hahn MM, et al. Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer. Gastroenterology. 2010;139(6):2221–4.CrossRefPubMed
8.
Zurück zum Zitat Venkatachalam R, Verwiel ET, Kamping EJ, Hoenselaar E, Gorgens H, Schackert HK, et al. Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients. Int J Cancer. 2011;129(7):1635–42.CrossRefPubMed Venkatachalam R, Verwiel ET, Kamping EJ, Hoenselaar E, Gorgens H, Schackert HK, et al. Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients. Int J Cancer. 2011;129(7):1635–42.CrossRefPubMed
9.
Zurück zum Zitat Riegert-Johnson DL, Johnson RA, Rabe KG, Wang L, Thomas B, Baudhuin LM, Thibodeau SN, Boardman LA. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing. Genet Test. 2007;11(4):361–5.CrossRefPubMed Riegert-Johnson DL, Johnson RA, Rabe KG, Wang L, Thomas B, Baudhuin LM, Thibodeau SN, Boardman LA. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing. Genet Test. 2007;11(4):361–5.CrossRefPubMed
10.
Zurück zum Zitat Nieminen TT, Abdel-Rahman WM, Ristimäki A, Lappalainen M, Lahermo P, Mecklin JP, Järvinen HJ, Peltomäki P. BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology. 2011;141(1):e23–6.CrossRefPubMed Nieminen TT, Abdel-Rahman WM, Ristimäki A, Lappalainen M, Lahermo P, Mecklin JP, Järvinen HJ, Peltomäki P. BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology. 2011;141(1):e23–6.CrossRefPubMed
11.
Zurück zum Zitat Fernandez-Rozadilla C, de Castro L, Clofent J, Brea-Fernandez A, Bessa X, Abuli A, et al. Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish cohort. PLoS One. 2010;5(9):e12673.CrossRefPubMedPubMedCentral Fernandez-Rozadilla C, de Castro L, Clofent J, Brea-Fernandez A, Bessa X, Abuli A, et al. Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish cohort. PLoS One. 2010;5(9):e12673.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, Cawley S, et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet. 2008;40(10):1253–60.CrossRefPubMedPubMedCentral Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, Cawley S, et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet. 2008;40(10):1253–60.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Colella S, Yau C, Taylor JM, Mirza G, Butler H, Clouston P, et al. QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res. 2007;35(6):2013–25.CrossRefPubMedPubMedCentral Colella S, Yau C, Taylor JM, Mirza G, Butler H, Clouston P, et al. QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res. 2007;35(6):2013–25.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet. 2007;81(3):559–75.CrossRefPubMedPubMedCentral Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet. 2007;81(3):559–75.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet. 2007;39(8):984–8.CrossRefPubMed Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet. 2007;39(8):984–8.CrossRefPubMed
16.
Zurück zum Zitat Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, et al. Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clin Colorectal Cancer. 2010;9(3):168–76.CrossRefPubMed Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, et al. Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clin Colorectal Cancer. 2010;9(3):168–76.CrossRefPubMed
17.
Zurück zum Zitat Azuara D, Rodriguez-Moranta F, de Oca J, Sanjuan X, Guardiola J, Lobaton T, et al. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn’s colitis patients. Inflamm Bowel Dis. 2013;19(1):165–73.CrossRefPubMed Azuara D, Rodriguez-Moranta F, de Oca J, Sanjuan X, Guardiola J, Lobaton T, et al. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn’s colitis patients. Inflamm Bowel Dis. 2013;19(1):165–73.CrossRefPubMed
18.
Zurück zum Zitat Fernandez-Rozadilla C, Cazier JB, Tomlinson I, Brea-Fernandez A, Lamas MJ, Baiget M, et al. A genome-wide association study on copy number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancer. Hum Genet. 2014;133(5):525–34.CrossRefPubMed Fernandez-Rozadilla C, Cazier JB, Tomlinson I, Brea-Fernandez A, Lamas MJ, Baiget M, et al. A genome-wide association study on copy number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancer. Hum Genet. 2014;133(5):525–34.CrossRefPubMed
19.
Zurück zum Zitat Li Z, Yu D, Gan M, Shan Q, Yin X, Tang S, Zhang S, Shi Y, Zhu Y, Lai M, Zhang D. A genome-wide assessment of rare copy number variants in colorectal cancer. Oncotarget. 2015;6(28):26411–23.CrossRefPubMedPubMedCentral Li Z, Yu D, Gan M, Shan Q, Yin X, Tang S, Zhang S, Shi Y, Zhu Y, Lai M, Zhang D. A genome-wide assessment of rare copy number variants in colorectal cancer. Oncotarget. 2015;6(28):26411–23.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Krepischi AC, Achatz MI, Santos EM, Costa SS, Lisboa BC, Brentani H, et al. Germline DNA copy number variation in familial and early-onset breast cancer. Breast Cancer Res. 2012;14(1):R24.CrossRefPubMedPubMedCentral Krepischi AC, Achatz MI, Santos EM, Costa SS, Lisboa BC, Brentani H, et al. Germline DNA copy number variation in familial and early-onset breast cancer. Breast Cancer Res. 2012;14(1):R24.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Zhou WJ, Geng ZH, Chi S, Zhang W, Niu XF, Lan SJ, et al. Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res. 2011;21:609–26.CrossRefPubMedPubMedCentral Zhou WJ, Geng ZH, Chi S, Zhang W, Niu XF, Lan SJ, et al. Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res. 2011;21:609–26.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Patai AV, Valcz G, Hollosi P, Kalmar A, Peterfia B, Patai A, et al. Comprehensive DNA methylation analysis reveals a common ten-gene methylation signature in colorectal adenomas and carcinomas. PLoS One. 2015;10(8):e0133836.CrossRefPubMedPubMedCentral Patai AV, Valcz G, Hollosi P, Kalmar A, Peterfia B, Patai A, et al. Comprehensive DNA methylation analysis reveals a common ten-gene methylation signature in colorectal adenomas and carcinomas. PLoS One. 2015;10(8):e0133836.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Beggs AD, Jones A, Shepherd N, Arnaout A, Finlayson C, Abulafi AM, et al. Loss of expression and promoter methylation of SLIT2 are associated with sessile serrated adenoma formation. PLoS Genet. 2013;9(5):e1003488.CrossRefPubMedPubMedCentral Beggs AD, Jones A, Shepherd N, Arnaout A, Finlayson C, Abulafi AM, et al. Loss of expression and promoter methylation of SLIT2 are associated with sessile serrated adenoma formation. PLoS Genet. 2013;9(5):e1003488.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Alvarez C, Tapia T, Cornejo V, Fernandez W, Munoz A, Camus M, et al. Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer. Mol Carcinog. 2013;52(6):475–87.CrossRefPubMed Alvarez C, Tapia T, Cornejo V, Fernandez W, Munoz A, Camus M, et al. Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer. Mol Carcinog. 2013;52(6):475–87.CrossRefPubMed
25.
Zurück zum Zitat Wang J, Yang DL, Chen ZZ, Gou BF. Associations of body mass index with cancer incidence among populations, genders, and menopausal status: a systematic review and meta-analysis. Cancer Epidemiol. 2016;42:1–8.CrossRefPubMed Wang J, Yang DL, Chen ZZ, Gou BF. Associations of body mass index with cancer incidence among populations, genders, and menopausal status: a systematic review and meta-analysis. Cancer Epidemiol. 2016;42:1–8.CrossRefPubMed
26.
Zurück zum Zitat Knudson AG. Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol. 1996;122(3):135–40.CrossRefPubMed Knudson AG. Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol. 1996;122(3):135–40.CrossRefPubMed
27.
Zurück zum Zitat Chopra AS, Kuratnik A, Scocchera EW, Wright DL, Giardina C. Identification of novel compounds that enhance colon cancer cell sensitivity to inflammatory apoptotic ligands. Cancer Biol Ther. 2013;14(5):436–49.CrossRefPubMedPubMedCentral Chopra AS, Kuratnik A, Scocchera EW, Wright DL, Giardina C. Identification of novel compounds that enhance colon cancer cell sensitivity to inflammatory apoptotic ligands. Cancer Biol Ther. 2013;14(5):436–49.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Laitinen VH, Akinrinade O, Rantapero T, Tammela TL, Wahlfors T, Schleutker J. Germline copy number variation analysis in Finnish families with hereditary prostate cancer. Prostate. 2016;76(3):316–24.CrossRefPubMed Laitinen VH, Akinrinade O, Rantapero T, Tammela TL, Wahlfors T, Schleutker J. Germline copy number variation analysis in Finnish families with hereditary prostate cancer. Prostate. 2016;76(3):316–24.CrossRefPubMed
29.
Zurück zum Zitat Moir-Meyer GL, Pearson JF, Lose F, Australian National Endometrial Cancer Study Group, Scott RJ, McEvoy M, et al. Rare germline copy number deletions of likely functional importance are implicated in endometrial cancer predisposition. Hum Genet. 2015;134(3):269–78.CrossRefPubMed Moir-Meyer GL, Pearson JF, Lose F, Australian National Endometrial Cancer Study Group, Scott RJ, McEvoy M, et al. Rare germline copy number deletions of likely functional importance are implicated in endometrial cancer predisposition. Hum Genet. 2015;134(3):269–78.CrossRefPubMed
Metadaten
Titel
Candidate predisposing germline copy number variants in early onset colorectal cancer patients
verfasst von
A. J. Brea-Fernandez
C. Fernandez-Rozadilla
M. Alvarez-Barona
D. Azuara
M. M. Ginesta
J. Clofent
L. de Castro
D. Gonzalez
M. Andreu
X. Bessa
X. Llor
R. Xicola
R. Jover
A. Castells
S. Castellvi-Bel
G. Capella
A. Carracedo
C. Ruiz-Ponte
Publikationsdatum
25.11.2016
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 5/2017
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-016-1576-z

Weitere Artikel der Ausgabe 5/2017

Clinical and Translational Oncology 5/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.